|Articles|April 1, 2009

Pharmacy Times

  • Volume 0
  • 0

Product Hotline

Soma 250 mg

Soma (carisoprodol) 250 mg, manufactured by Meda Pharmaceuticals Inc (Somerset, NJ), is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. The recommended dose is 250 to 350 mg 3 times a day and at bedtime. The recommended maximum duration of Soma use is up to 2 or 3 weeks.

www.soma250.com

Kapidex

Kapidex (dexlansoprazole) delayedrelease capsules, manufactured by Takeda Pharmaceuticals North America Inc (Deerfield, IL), recently received FDA approval for the once-daily oral treatment of heartburn associated with symptomatic, nonerosive gastroesophageal reflux disease, the healing of erosive esophagitis, and the maintenance of healed erosive esophagitis. The product is available in 30- and 60-mg capsules.

www.kapidex.com

Symbicort

AstraZeneca (Wilmington, DE) recently received FDA approval for Symbicort (budesonide/formoterol fumarate dihydrate) 160/4.5 mcg for the twice daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. Symbicort also is indicated for the maintenance treatment of asthma in patients 12 years and older.

www.mysymbicort.com

Articles in this issue

over 16 years ago

Women's Health Watch

over 16 years ago

Case Studies

over 16 years ago

Can You Read These Rxs?

over 16 years ago

Arthritis Watch

over 16 years ago

Diabetes Watch

over 16 years ago

Asthma Watch

over 16 years ago

Pharmacy Technology Products

over 16 years ago

Pharmacy Technology News

over 16 years ago

Outlook: Obesity Epidemic

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME